Psoriasis is a chronic disease and often requires long‐term treatment, especially in patients
with moderate‐to‐severe psoriasis. It remains controversial whether the doses of systemic …

Systemic agents such as methotrexate and cyclo‐sporine are commonly used in the
treatment of psoriasis. Long‐term continuous use is not recommended due to potential …

BACKGROUND: Despite widespread dissatisfaction and low treatment persistence in
moderate to severe psoriasis, patients' reasons behind treatment discontinuation remain …

Switching psoriasis treatment is a common, accepted practice that is used to improve
disease management and improve patient outcomes (eg, when patients are experiencing …

Background: Psoriasis treatment involves multiple treatment arms. Treatment choice
depends on many factors and may change, due to the chronicity of psoriasis. Objective: The …

Abstract Background/Objective: The purpose of our study was to provide evidence on the
treatment choices, reasons, and results of switching between biologic agents in treating …

Background Drug survival is useful to evaluate long‐term drug performance in daily practice.
The aim of this study was to evaluate drug survival for methotrexate (MTX) monotherapy in …

Introduction Biologics serve as a cornerstone in psoriasis treatment, with low disease activity
or sometimes even clinical remission as a realistic treatment outcome. So far, it is unclear …

Background Methotrexate and cyclosporine are well-known systemic therapies for moderate-
to-severe chronic plaque psoriasis. We conduced a randomized, controlled trial comparing …

Background Psoriasis patients frequently switch among multiple therapies while managing
their psoriasis. Determining treatment transitions is fundamental to understanding how …